文献速递腹部MR

对比增强与扩散加权MRI评估克罗恩病患者末端回肠的比较

Comparison of contrast-enhanced and diffusion-weighted MRI in assessment of the terminal ileum in Crohn's disease patients.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

该研究纳入61例克罗恩病患者,由3名阅片者分别评估对比增强MRI、扩散加权MRI及其组合方案对末端回肠病变活动度的分级,并与CDEIS相关。结果显示各方案诊断准确度介于0.74至0.85,活动度分级与CDEIS相关系数介于0.66至0.75;对比增强MRI与扩散加权MRI在判断疾病活动度上无显著差异,但对比增强MRI的置信水平显著更高(P < 0.001)。

要点

  • 对比增强MRI与扩散加权MRI判断末端回肠克罗恩病活动度无显著差异。
  • 对比增强MRI的阅片置信水平显著高于扩散加权MRI(P < 0.001)。
  • 联合方案可进一步提高置信水平,扩散加权MRI可用于存在静脉对比剂相对禁忌者。

核心结论

  • 对比增强MRI与扩散加权MRI在判断末端回肠克罗恩病活动度方面无显著差异,但对比增强MRI的置信水平更高;扩散加权MRI是存在静脉对比剂使用相对禁忌证时的良好替代方案。

研究设计与样本

  • 研究纳入61例患者(30例女性,中位年龄36岁),由3名阅片者评估对比增强MRI、扩散加权MRI及其组合方案,以CDEIS为参考标准比较诊断准确度、活动度分级和置信水平,并计算阅片者间一致性。

诊断标准与关键数值

  • 对比增强MRI诊断活动性疾病的准确度范围为0.82至0.85。
  • 扩散加权MRI诊断活动性疾病的准确度范围为0.75至0.83。
  • 先对比增强后扩散加权MRI组合方案的诊断准确度范围为0.79至0.84。
  • 先扩散加权后对比增强MRI组合方案的诊断准确度范围为0.74至0.82。
  • 对比增强MRI活动度分级与CDEIS的相关系数范围为0.70至0.74;扩散加权MRI为0.66至0.70;先对比增强后扩散加权组合为0.69至0.75;先扩散加权后对比增强组合为0.67至0.74。

临床应用与阅片要点

  • 作者认为扩散加权MRI可作为存在静脉对比剂相对禁忌证患者的良好替代方案;对比增强MRI的阅片置信水平显著更高(P < 0.001),联合方案可进一步提高置信水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The purpose of the study was to compare the performance of contrast-enhanced (CE)-MRI and diffusion-weighted imaging (DW)-MRI in grading Crohn's disease activity of the terminal ileum.

METHODS: Three readers evaluated CE-MRI, DW-MRI, and their combinations (CE/DW-MRI and DW/CE-MRI, depending on which protocol was used at the start of evaluation). Disease severity grading scores were correlated to the Crohn's Disease Endoscopic Index of Severity (CDEIS). Diagnostic accuracy, severity grading, and levels of confidence were compared between imaging protocols and interobserver agreement was calculated.

RESULTS: Sixty-one patients were included (30 female, median age 36). Diagnostic accuracy for active disease for CE-MRI, DW-MRI, CE/DW-MRI, and DW/CE-MRI ranged between 0.82 and 0.85, 0.75 and 0.83, 0.79 and 0.84, and 0.74 and 0.82, respectively. Severity grading correlation to CDEIS ranged between 0.70 and 0.74, 0.66 and 0.70, 0.69 and 0.75, and 0.67 and 0.74, respectively. For each reader, CE-MRI values were consistently higher than DW-MRI, albeit not significantly. Confidence levels for all readers were significantly higher for CE-MRI compared to DW-MRI (P < 0.001). Further increased confidence was seen when using combined imaging protocols.

CONCLUSIONS: There was no significant difference of CE-MRI and DW-MRI in determining disease activity, but the higher confidence levels may favor CE-MRI. DW-MRI is a good alternative in cases with relative contraindications for the use of intravenous contrast medium.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Puylaert CAJ, Tielbeek JAW, Schüffler PJ, et al. Comparison of contrast-enhanced and diffusion-weighted MRI in assessment of the terminal ileum in Crohn's disease patients. Abdom Radiol (NY). 2019. PMID: 30109377. doi:10.1007/s00261-018-1734-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。